Ibrutinib-induced pneumonitis in chronic lymphocytic leukemia patient

oa Ibrutinib-induced pneumonitis in chronic lymphocytic leukemia patient
By Salem Salah¹
View Affiliations Hide Affiliations

Affiliations: ¹ Hamad General Hospital, Doha, Qatar Email: [email protected]
Source: Qatar Medical Journal, Volume 2024, Issue 2 - Qatar Thoracic Conference, Apr 2024, 15
DOI: https://doi.org/10.5339/qmj.2024.qitc.15
- Received: 15 January 2024
- Accepted: 02 February 2024
- Published online: 25 March 2024

Article metrics loading...

/content/journals/10.5339/qmj.2024.qitc.15

2024-03-25

2024-12-06

Full text loading...

/deliver/fulltext/qmj/2024/2/qmj.qitc.15.html?itemId=/content/journals/10.5339/qmj.2024.qitc.15&mimeType=html&fmt=ahah

References

Reza S, Jean S, Marc F. Ibrutinib-induced interstitial lung disease. Chest. 2015; 148:(4):365A.
[Google Scholar]
Sesemann L, Cooper T. A case report of ibrutinib-induced pneumonitis. Chest. 2021; 160:(4):A1721.
[Google Scholar]
Up to date, drug information (Ibrutinib) https://www.uptodate.com/IBRUTINIB.

/content/journals/10.5339/qmj.2024.qitc.15

Ibrutinib-induced pneumonitis in chronic lymphocytic leukemia patient

Qatar Medical Journal 2024, 15 (2024); https://doi.org/10.5339/qmj.2024.qitc.15

/content/journals/10.5339/qmj.2024.qitc.15

Data & Media loading...

Keyword(s): Drug Induced, Ibrutinib, Ild and Pneumonitis

oa Ibrutinib-induced pneumonitis in chronic lymphocytic leukemia patient